In vivo efficacy and safety of artemether–lumefantrine and amodiaquine–artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018

Abstract Background Artemisinin-based combination therapy (ACT) has been the recommended first-line treatment for uncomplicated malaria in Mozambique since 2006, with artemether–lumefantrine (AL) and amodiaquine–artesunate (AS–AQ) as the first choice. To assess efficacy of currently used ACT, an in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Abel Nhama, Lídia Nhamússua, Eusébio Macete, Quique Bassat, Crizolgo Salvador, Sónia Enosse, Baltazar Candrinho, Eva Carvalho, Arsénio Nhacolo, Arlindo Chidimatembue, Abuchahama Saifodine, Rose Zulliger, Naomi Lucchi, Samaly S. Svigel, Leah F. Moriarty, Eric S. Halsey, Alfredo Mayor, Pedro Aide
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2021-10-01
Col·lecció:	Malaria Journal
Matèries:	Efficacy Artemether–lumefantrine Artesunate–amodiaquine Uncomplicated malaria Children Mozambique
Accés en línia:	https://doi.org/10.1186/s12936-021-03922-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!